The role of health technology assessment in the comprehensive evaluation of the impact of immunotherapy on real practice.
D000818:Animals; D035843:Biomedical Research / Q000191:economics* / Q000458:organization & administration; D020811:Biomedical Technology / Q000191:economics* / Q000458:organization & administration; D003362:Cost-Benefit Analysis; D003888:Desensitization, Immunologic / Q000191:economics / Q000941:ethics; D017048:Health Care Costs; D006291:Health Policy; D006301:Health Services Needs and Demand / Q000191:economics / Q000458:organization & administration; D006801:Humans; D006967:Hypersensitivity / Q000191:economics / Q000453:epidemiology / Q000628:therapy*; D007167:Immunotherapy / Q000191:economics* / Q000941:ethics; D033183:Interdisciplinary Communication; D005791:Patient Care / Q000191:economics; D011785:Quality Assurance, Health Care / Q000191:economics / Q000458:organization & administration